Search





Search





Markets
/
Stocks
/
crdf
/

Cardiff Oncology Inc

CRDF

Add to Watchlist

0.855USD

+0.004+0.52%

Close 07-31 16:00（ET）Quotes delayed by 15 min

58.48MMarket Cap

LossP/E TTM

Cardiff Oncology Inc

0.855

+0.004+0.52%

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Overview

Financials

Discussions

Analysis

Company

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Institutional Confidence

Currency: USD Updated: 2026-07-31

Previous score

3.00

Change

The current institutional shareholding score of Cardiff Oncology Inc is 3.00, ranking 192 out of 385 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 35.32%, representing a quarter-over-quarter decrease of 33.21%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 0.15% of shares outstanding, with 1.28% increase in holdings.

Institutional Shareholding

Shareholder Activity

Name

Shares Held

Chg %

BlackRock Institutional Trust Company, N.A.

3.69M

+1.60%

Laurion Capital Management LP

2.65M

+7.33%

Pfizer Inc

2.41M

Acorn Capital Advisors, LLC

1.96M

Geode Capital Management, L.L.C.

1.52M

-1.32%

Pace (Gary William)

1.33M

+26.05%

Franklin Advisers, Inc.

1.21M

State Street Investment Management (US)

1.19M

+3.95%

Two Sigma Investments, LP

1.09M

+340.64%